Th17: the third member of the effector T cell trilogy
- 31 December 2007
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 19 (6), 652-657
- https://doi.org/10.1016/j.coi.2007.07.020
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- IL-25 regulates Th17 function in autoimmune inflammationThe Journal of Experimental Medicine, 2007
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesThe Journal of Experimental Medicine, 2006
- T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17The Journal of Experimental Medicine, 2006
- T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotypeBlood, 2006
- Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitisJCI Insight, 2006
- Transforming growth factor-β induces development of the TH17 lineageNature, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae The Journal of Experimental Medicine, 2005
- Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiationNature Reviews Immunology, 2005
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003